Related Experiment Video

Updated: Oct 15, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Calcium and sodium channel antagonists for the treatment of pain

M S Wallace1

  • 1Department of Anesthesiology, University of California, San Diego, School of Medicine, La Jolla 92093-0924, USA. mswallace@ucsd.edu

The Clinical Journal of Pain
|June 28, 2000
PubMed

Insights

Voltage-sensitive sodium and calcium channels play a role in pain. Antagonists show mixed results for acute and chronic pain, with N-type calcium channel antagonists showing promise.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Preclinical models indicate voltage-sensitive sodium and calcium channels are crucial for spontaneous and evoked pain.
  • These channels are prevalent in both peripheral and central nervous systems, making them key targets for pain management.
  • Extensive research exists on sodium and calcium channel antagonists' effects on nociceptive processing.

Purpose of the Study:

  • To review the current literature on the impact of sodium and calcium channel antagonists on pain.
  • To examine their effects on acute nociceptive processing, facilitated pain, and neuropathic pain.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of research on sodium channel antagonists.
  • Evaluation of preliminary findings for N-type calcium channel antagonists.

Main Results:

  • Clinical efficacy of sodium channel antagonists for acute and chronic pain has yielded mixed results.
  • Preliminary studies on N-type calcium channel antagonists for pain management are promising but require further investigation.
  • The role of these channels in various pain types is complex and under active research.

Conclusions:

  • Voltage-sensitive sodium and calcium channels are significant modulators of pain signaling.
  • Current therapeutic strategies using channel antagonists present challenges and opportunities.
  • Further research, particularly on specific antagonists like N-type calcium channel blockers, is warranted for effective pain treatment.

More Related Videos

Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat08:05

Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat

Published on: November 21, 2025

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...